 | • レポートコード：QFJ1-4841 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、仙骨神経刺激システムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（内部神経調節システム、外部神経調節システム）、用途別市場規模（脊髄刺激、脳深部刺激、仙骨神経刺激、迷走神経刺激）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・仙骨神経刺激システムの市場動向 ・企業の競争状況、市場シェア ・仙骨神経刺激システムの種類別市場規模と予測2016-2027（内部神経調節システム、外部神経調節システム） ・仙骨神経刺激システムの用途別市場規模と予測2016-2027（脊髄刺激、脳深部刺激、仙骨神経刺激、迷走神経刺激） ・仙骨神経刺激システムの北米市場規模2016-2027（アメリカ、カナダ） ・仙骨神経刺激システムの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・仙骨神経刺激システムのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・仙骨神経刺激システムの中南米市場規模2016-2027（メキシコ、ブラジル） ・仙骨神経刺激システムの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Medtronic, Inc. (US)、Boston Scientific Corporation (US)、St. Jude Medical, Inc. (US)、Synapse Biomedical, Inc. (US)、Nevro Corporation (US)、Neurosigma, Inc. (US)、Neuropace, Inc. (US)、Neuronetics, Inc. (US)、Cyberonics, Inc. (US)、BioControl Medical (Israel)） ・結論 |
Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities.
Market Analysis and Insights: Global Sacral Neuromodulation System Market
The global Sacral Neuromodulation System market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sacral Neuromodulation System market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sacral Neuromodulation System market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sacral Neuromodulation System market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sacral Neuromodulation System market.
Global Sacral Neuromodulation System Scope and Market Size
Sacral Neuromodulation System market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sacral Neuromodulation System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Internal Neuromodulation System
External Neuromodulation System
Segment by Application
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Medtronic, Inc. (US)
Boston Scientific Corporation (US)
St. Jude Medical, Inc. (US)
Synapse Biomedical, Inc. (US)
Nevro Corporation (US)
Neurosigma, Inc. (US)
Neuropace, Inc. (US)
Neuronetics, Inc. (US)
Cyberonics, Inc. (US)
BioControl Medical (Israel)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sacral Neuromodulation System Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Internal Neuromodulation System
1.2.3 External Neuromodulation System
1.3 Market by Application
1.3.1 Global Sacral Neuromodulation System Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Spinal Cord Stimulation
1.3.3 Deep Brain Stimulation
1.3.4 Sacral Nerve Stimulation
1.3.5 Vagus Nerve Stimulation
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sacral Neuromodulation System Market Perspective (2016-2027)
2.2 Sacral Neuromodulation System Growth Trends by Regions
2.2.1 Sacral Neuromodulation System Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sacral Neuromodulation System Historic Market Share by Regions (2016-2021)
2.2.3 Sacral Neuromodulation System Forecasted Market Size by Regions (2022-2027)
2.3 Sacral Neuromodulation System Industry Dynamic
2.3.1 Sacral Neuromodulation System Market Trends
2.3.2 Sacral Neuromodulation System Market Drivers
2.3.3 Sacral Neuromodulation System Market Challenges
2.3.4 Sacral Neuromodulation System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sacral Neuromodulation System Players by Revenue
3.1.1 Global Top Sacral Neuromodulation System Players by Revenue (2016-2021)
3.1.2 Global Sacral Neuromodulation System Revenue Market Share by Players (2016-2021)
3.2 Global Sacral Neuromodulation System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sacral Neuromodulation System Revenue
3.4 Global Sacral Neuromodulation System Market Concentration Ratio
3.4.1 Global Sacral Neuromodulation System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sacral Neuromodulation System Revenue in 2020
3.5 Sacral Neuromodulation System Key Players Head office and Area Served
3.6 Key Players Sacral Neuromodulation System Product Solution and Service
3.7 Date of Enter into Sacral Neuromodulation System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sacral Neuromodulation System Breakdown Data by Type
4.1 Global Sacral Neuromodulation System Historic Market Size by Type (2016-2021)
4.2 Global Sacral Neuromodulation System Forecasted Market Size by Type (2022-2027)
5 Sacral Neuromodulation System Breakdown Data by Application
5.1 Global Sacral Neuromodulation System Historic Market Size by Application (2016-2021)
5.2 Global Sacral Neuromodulation System Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Sacral Neuromodulation System Market Size (2016-2027)
6.2 North America Sacral Neuromodulation System Market Size by Type
6.2.1 North America Sacral Neuromodulation System Market Size by Type (2016-2021)
6.2.2 North America Sacral Neuromodulation System Market Size by Type (2022-2027)
6.2.3 North America Sacral Neuromodulation System Market Size by Type (2016-2027)
6.3 North America Sacral Neuromodulation System Market Size by Application
6.3.1 North America Sacral Neuromodulation System Market Size by Application (2016-2021)
6.3.2 North America Sacral Neuromodulation System Market Size by Application (2022-2027)
6.3.3 North America Sacral Neuromodulation System Market Size by Application (2016-2027)
6.4 North America Sacral Neuromodulation System Market Size by Country
6.4.1 North America Sacral Neuromodulation System Market Size by Country (2016-2021)
6.4.2 North America Sacral Neuromodulation System Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Sacral Neuromodulation System Market Size (2016-2027)
7.2 Europe Sacral Neuromodulation System Market Size by Type
7.2.1 Europe Sacral Neuromodulation System Market Size by Type (2016-2021)
7.2.2 Europe Sacral Neuromodulation System Market Size by Type (2022-2027)
7.2.3 Europe Sacral Neuromodulation System Market Size by Type (2016-2027)
7.3 Europe Sacral Neuromodulation System Market Size by Application
7.3.1 Europe Sacral Neuromodulation System Market Size by Application (2016-2021)
7.3.2 Europe Sacral Neuromodulation System Market Size by Application (2022-2027)
7.3.3 Europe Sacral Neuromodulation System Market Size by Application (2016-2027)
7.4 Europe Sacral Neuromodulation System Market Size by Country
7.4.1 Europe Sacral Neuromodulation System Market Size by Country (2016-2021)
7.4.2 Europe Sacral Neuromodulation System Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Sacral Neuromodulation System Market Size (2016-2027)
8.2 Asia-Pacific Sacral Neuromodulation System Market Size by Type
8.2.1 Asia-Pacific Sacral Neuromodulation System Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sacral Neuromodulation System Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sacral Neuromodulation System Market Size by Type (2016-2027)
8.3 Asia-Pacific Sacral Neuromodulation System Market Size by Application
8.3.1 Asia-Pacific Sacral Neuromodulation System Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sacral Neuromodulation System Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sacral Neuromodulation System Market Size by Application (2016-2027)
8.4 Asia-Pacific Sacral Neuromodulation System Market Size by Region
8.4.1 Asia-Pacific Sacral Neuromodulation System Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sacral Neuromodulation System Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sacral Neuromodulation System Market Size (2016-2027)
9.2 Latin America Sacral Neuromodulation System Market Size by Type
9.2.1 Latin America Sacral Neuromodulation System Market Size by Type (2016-2021)
9.2.2 Latin America Sacral Neuromodulation System Market Size by Type (2022-2027)
9.2.3 Latin America Sacral Neuromodulation System Market Size by Type (2016-2027)
9.3 Latin America Sacral Neuromodulation System Market Size by Application
9.3.1 Latin America Sacral Neuromodulation System Market Size by Application (2016-2021)
9.3.2 Latin America Sacral Neuromodulation System Market Size by Application (2022-2027)
9.3.3 Latin America Sacral Neuromodulation System Market Size by Application (2016-2027)
9.4 Latin America Sacral Neuromodulation System Market Size by Country
9.4.1 Latin America Sacral Neuromodulation System Market Size by Country (2016-2021)
9.4.2 Latin America Sacral Neuromodulation System Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sacral Neuromodulation System Market Size (2016-2027)
10.2 Middle East & Africa Sacral Neuromodulation System Market Size by Type
10.2.1 Middle East & Africa Sacral Neuromodulation System Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sacral Neuromodulation System Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sacral Neuromodulation System Market Size by Type (2016-2027)
10.3 Middle East & Africa Sacral Neuromodulation System Market Size by Application
10.3.1 Middle East & Africa Sacral Neuromodulation System Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sacral Neuromodulation System Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sacral Neuromodulation System Market Size by Application (2016-2027)
10.4 Middle East & Africa Sacral Neuromodulation System Market Size by Country
10.4.1 Middle East & Africa Sacral Neuromodulation System Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sacral Neuromodulation System Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Medtronic, Inc. (US)
11.1.1 Medtronic, Inc. (US) Company Details
11.1.2 Medtronic, Inc. (US) Business Overview
11.1.3 Medtronic, Inc. (US) Sacral Neuromodulation System Introduction
11.1.4 Medtronic, Inc. (US) Revenue in Sacral Neuromodulation System Business (2016-2021)
11.1.5 Medtronic, Inc. (US) Recent Development
11.2 Boston Scientific Corporation (US)
11.2.1 Boston Scientific Corporation (US) Company Details
11.2.2 Boston Scientific Corporation (US) Business Overview
11.2.3 Boston Scientific Corporation (US) Sacral Neuromodulation System Introduction
11.2.4 Boston Scientific Corporation (US) Revenue in Sacral Neuromodulation System Business (2016-2021)
11.2.5 Boston Scientific Corporation (US) Recent Development
11.3 St. Jude Medical, Inc. (US)
11.3.1 St. Jude Medical, Inc. (US) Company Details
11.3.2 St. Jude Medical, Inc. (US) Business Overview
11.3.3 St. Jude Medical, Inc. (US) Sacral Neuromodulation System Introduction
11.3.4 St. Jude Medical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2016-2021)
11.3.5 St. Jude Medical, Inc. (US) Recent Development
11.4 Synapse Biomedical, Inc. (US)
11.4.1 Synapse Biomedical, Inc. (US) Company Details
11.4.2 Synapse Biomedical, Inc. (US) Business Overview
11.4.3 Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Introduction
11.4.4 Synapse Biomedical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2016-2021)
11.4.5 Synapse Biomedical, Inc. (US) Recent Development
11.5 Nevro Corporation (US)
11.5.1 Nevro Corporation (US) Company Details
11.5.2 Nevro Corporation (US) Business Overview
11.5.3 Nevro Corporation (US) Sacral Neuromodulation System Introduction
11.5.4 Nevro Corporation (US) Revenue in Sacral Neuromodulation System Business (2016-2021)
11.5.5 Nevro Corporation (US) Recent Development
11.6 Neurosigma, Inc. (US)
11.6.1 Neurosigma, Inc. (US) Company Details
11.6.2 Neurosigma, Inc. (US) Business Overview
11.6.3 Neurosigma, Inc. (US) Sacral Neuromodulation System Introduction
11.6.4 Neurosigma, Inc. (US) Revenue in Sacral Neuromodulation System Business (2016-2021)
11.6.5 Neurosigma, Inc. (US) Recent Development
11.7 Neuropace, Inc. (US)
11.7.1 Neuropace, Inc. (US) Company Details
11.7.2 Neuropace, Inc. (US) Business Overview
11.7.3 Neuropace, Inc. (US) Sacral Neuromodulation System Introduction
11.7.4 Neuropace, Inc. (US) Revenue in Sacral Neuromodulation System Business (2016-2021)
11.7.5 Neuropace, Inc. (US) Recent Development
11.8 Neuronetics, Inc. (US)
11.8.1 Neuronetics, Inc. (US) Company Details
11.8.2 Neuronetics, Inc. (US) Business Overview
11.8.3 Neuronetics, Inc. (US) Sacral Neuromodulation System Introduction
11.8.4 Neuronetics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2016-2021)
11.8.5 Neuronetics, Inc. (US) Recent Development
11.9 Cyberonics, Inc. (US)
11.9.1 Cyberonics, Inc. (US) Company Details
11.9.2 Cyberonics, Inc. (US) Business Overview
11.9.3 Cyberonics, Inc. (US) Sacral Neuromodulation System Introduction
11.9.4 Cyberonics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2016-2021)
11.9.5 Cyberonics, Inc. (US) Recent Development
11.10 BioControl Medical (Israel)
11.10.1 BioControl Medical (Israel) Company Details
11.10.2 BioControl Medical (Israel) Business Overview
11.10.3 BioControl Medical (Israel) Sacral Neuromodulation System Introduction
11.10.4 BioControl Medical (Israel) Revenue in Sacral Neuromodulation System Business (2016-2021)
11.10.5 BioControl Medical (Israel) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Sacral Neuromodulation System Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Internal Neuromodulation System
Table 3. Key Players of External Neuromodulation System
Table 4. Global Sacral Neuromodulation System Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Sacral Neuromodulation System Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Sacral Neuromodulation System Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Sacral Neuromodulation System Market Share by Regions (2016-2021)
Table 8. Global Sacral Neuromodulation System Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Sacral Neuromodulation System Market Share by Regions (2022-2027)
Table 10. Sacral Neuromodulation System Market Trends
Table 11. Sacral Neuromodulation System Market Drivers
Table 12. Sacral Neuromodulation System Market Challenges
Table 13. Sacral Neuromodulation System Market Restraints
Table 14. Global Sacral Neuromodulation System Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Sacral Neuromodulation System Market Share by Players (2016-2021)
Table 16. Global Top Sacral Neuromodulation System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sacral Neuromodulation System as of 2020)
Table 17. Ranking of Global Top Sacral Neuromodulation System Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Sacral Neuromodulation System Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Sacral Neuromodulation System Product Solution and Service
Table 21. Date of Enter into Sacral Neuromodulation System Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sacral Neuromodulation System Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Sacral Neuromodulation System Revenue Market Share by Type (2016-2021)
Table 25. Global Sacral Neuromodulation System Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Sacral Neuromodulation System Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Sacral Neuromodulation System Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Sacral Neuromodulation System Revenue Market Share by Application (2016-2021)
Table 29. Global Sacral Neuromodulation System Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Sacral Neuromodulation System Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Sacral Neuromodulation System Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Sacral Neuromodulation System Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Sacral Neuromodulation System Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Sacral Neuromodulation System Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Sacral Neuromodulation System Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Sacral Neuromodulation System Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Sacral Neuromodulation System Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Sacral Neuromodulation System Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Sacral Neuromodulation System Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Sacral Neuromodulation System Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Sacral Neuromodulation System Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Sacral Neuromodulation System Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Sacral Neuromodulation System Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Sacral Neuromodulation System Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Sacral Neuromodulation System Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Sacral Neuromodulation System Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Sacral Neuromodulation System Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Sacral Neuromodulation System Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Sacral Neuromodulation System Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Sacral Neuromodulation System Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Sacral Neuromodulation System Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Sacral Neuromodulation System Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Sacral Neuromodulation System Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Sacral Neuromodulation System Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Sacral Neuromodulation System Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Sacral Neuromodulation System Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Sacral Neuromodulation System Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Sacral Neuromodulation System Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Sacral Neuromodulation System Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Sacral Neuromodulation System Market Size by Country (2022-2027) & (US$ Million)
Table 61. Medtronic, Inc. (US) Company Details
Table 62. Medtronic, Inc. (US) Business Overview
Table 63. Medtronic, Inc. (US) Sacral Neuromodulation System Product
Table 64. Medtronic, Inc. (US) Revenue in Sacral Neuromodulation System Business (2016-2021) & (US$ Million)
Table 65. Medtronic, Inc. (US) Recent Development
Table 66. Boston Scientific Corporation (US) Company Details
Table 67. Boston Scientific Corporation (US) Business Overview
Table 68. Boston Scientific Corporation (US) Sacral Neuromodulation System Product
Table 69. Boston Scientific Corporation (US) Revenue in Sacral Neuromodulation System Business (2016-2021) & (US$ Million)
Table 70. Boston Scientific Corporation (US) Recent Development
Table 71. St. Jude Medical, Inc. (US) Company Details
Table 72. St. Jude Medical, Inc. (US) Business Overview
Table 73. St. Jude Medical, Inc. (US) Sacral Neuromodulation System Product
Table 74. St. Jude Medical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2016-2021) & (US$ Million)
Table 75. St. Jude Medical, Inc. (US) Recent Development
Table 76. Synapse Biomedical, Inc. (US) Company Details
Table 77. Synapse Biomedical, Inc. (US) Business Overview
Table 78. Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Product
Table 79. Synapse Biomedical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2016-2021) & (US$ Million)
Table 80. Synapse Biomedical, Inc. (US) Recent Development
Table 81. Nevro Corporation (US) Company Details
Table 82. Nevro Corporation (US) Business Overview
Table 83. Nevro Corporation (US) Sacral Neuromodulation System Product
Table 84. Nevro Corporation (US) Revenue in Sacral Neuromodulation System Business (2016-2021) & (US$ Million)
Table 85. Nevro Corporation (US) Recent Development
Table 86. Neurosigma, Inc. (US) Company Details
Table 87. Neurosigma, Inc. (US) Business Overview
Table 88. Neurosigma, Inc. (US) Sacral Neuromodulation System Product
Table 89. Neurosigma, Inc. (US) Revenue in Sacral Neuromodulation System Business (2016-2021) & (US$ Million)
Table 90. Neurosigma, Inc. (US) Recent Development
Table 91. Neuropace, Inc. (US) Company Details
Table 92. Neuropace, Inc. (US) Business Overview
Table 93. Neuropace, Inc. (US) Sacral Neuromodulation System Product
Table 94. Neuropace, Inc. (US) Revenue in Sacral Neuromodulation System Business (2016-2021) & (US$ Million)
Table 95. Neuropace, Inc. (US) Recent Development
Table 96. Neuronetics, Inc. (US) Company Details
Table 97. Neuronetics, Inc. (US) Business Overview
Table 98. Neuronetics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2016-2021) & (US$ Million)
Table 99. Neuronetics, Inc. (US) Recent Development
Table 100. Cyberonics, Inc. (US) Company Details
Table 101. Cyberonics, Inc. (US) Business Overview
Table 102. Cyberonics, Inc. (US) Sacral Neuromodulation System Product
Table 103. Cyberonics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2016-2021) & (US$ Million)
Table 104. Cyberonics, Inc. (US) Recent Development
Table 105. BioControl Medical (Israel) Company Details
Table 106. BioControl Medical (Israel) Business Overview
Table 107. BioControl Medical (Israel) Sacral Neuromodulation System Product
Table 108. BioControl Medical (Israel) Revenue in Sacral Neuromodulation System Business (2016-2021) & (US$ Million)
Table 109. BioControl Medical (Israel) Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sacral Neuromodulation System Market Share by Type: 2020 VS 2027
Figure 2. Internal Neuromodulation System Features
Figure 3. External Neuromodulation System Features
Figure 4. Global Sacral Neuromodulation System Market Share by Application: 2020 VS 2027
Figure 5. Spinal Cord Stimulation Case Studies
Figure 6. Deep Brain Stimulation Case Studies
Figure 7. Sacral Nerve Stimulation Case Studies
Figure 8. Vagus Nerve Stimulation Case Studies
Figure 9. Sacral Neuromodulation System Report Years Considered
Figure 10. Global Sacral Neuromodulation System Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Sacral Neuromodulation System Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Sacral Neuromodulation System Market Share by Regions: 2020 VS 2027
Figure 13. Global Sacral Neuromodulation System Market Share by Regions (2022-2027)
Figure 14. Global Sacral Neuromodulation System Market Share by Players in 2020
Figure 15. Global Top Sacral Neuromodulation System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sacral Neuromodulation System as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Sacral Neuromodulation System Revenue in 2020
Figure 17. Global Sacral Neuromodulation System Revenue Market Share by Type (2016-2021)
Figure 18. Global Sacral Neuromodulation System Revenue Market Share by Type (2022-2027)
Figure 19. North America Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Sacral Neuromodulation System Market Share by Type (2016-2027)
Figure 21. North America Sacral Neuromodulation System Market Share by Application (2016-2027)
Figure 22. North America Sacral Neuromodulation System Market Share by Country (2016-2027)
Figure 23. United States Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Sacral Neuromodulation System Market Share by Type (2016-2027)
Figure 27. Europe Sacral Neuromodulation System Market Share by Application (2016-2027)
Figure 28. Europe Sacral Neuromodulation System Market Share by Country (2016-2027)
Figure 29. Germany Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Sacral Neuromodulation System Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Sacral Neuromodulation System Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Sacral Neuromodulation System Market Share by Region (2016-2027)
Figure 39. China Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Sacral Neuromodulation System Market Share by Type (2016-2027)
Figure 47. Latin America Sacral Neuromodulation System Market Share by Application (2016-2027)
Figure 48. Latin America Sacral Neuromodulation System Market Share by Country (2016-2027)
Figure 49. Mexico Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Sacral Neuromodulation System Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Sacral Neuromodulation System Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Sacral Neuromodulation System Market Share by Country (2016-2027)
Figure 55. Turkey Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Sacral Neuromodulation System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Medtronic, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2016-2021)
Figure 59. Boston Scientific Corporation (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2016-2021)
Figure 60. St. Jude Medical, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2016-2021)
Figure 61. Synapse Biomedical, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2016-2021)
Figure 62. Nevro Corporation (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2016-2021)
Figure 63. Neurosigma, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2016-2021)
Figure 64. Neuropace, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2016-2021)
Figure 65. Neuronetics, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2016-2021)
Figure 66. Cyberonics, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2016-2021)
Figure 67. BioControl Medical (Israel) Revenue Growth Rate in Sacral Neuromodulation System Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界のパーキンソン病における脳深部刺激療法市場規模・現状・予測（2021年-2027年） Deep brain stimulation (DBS) is a neurosurgical procedure involving the placement of a medical device called a neurostimulator (sometimes referred to as a "brain pacemaker"), which sends electrical impulses, through implanted electrodes, to specific targets in the brain. DBS is used to manage some o…- 世界の脊髄刺激療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Spinal Cord Stimulation Therapy Market The global Spinal Cord Stimulation Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
- 神経刺激装置のグローバル市場調査 2019年 The global Neuro Stimulation Devices market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Neuro Stimulation Devices volume and value at global level, regional level and company level. From a global persp…
- 神経刺激及び神経調節デバイスのグローバル市場調査 2019年 The global Neurostimulation and Neuromodulation Device market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Neurostimulation and Neuromodulation Device volume and value at global level, regional level an…
- 世界のダイナミック脊椎テザリングシステム市場規模・現状・予測（2021年-2027年） Dynamic spinal tethering systems are used for the correction of irregular spine in adults as well as pediatrics. The dynamic spinal tethering systems are generally used in the patients suffering from the scoliosis or any other form of the spine deformity. The tether is anchored using the dynamic sys…